您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > AMXI-5001
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
AMXI-5001
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
AMXI-5001图片
CAS NO:2170491-77-5
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议

产品介绍
AMXI-5001 是一种有效的、具有口服活性的 parp1/2 和微管聚合抑制剂。MXI-5001 对多种人类癌细胞表现出选择性抗肿瘤细胞毒性,其 IC50s 比现有的临床 PARP1/2 抑制剂低得多。AMXI-5001 诱导已建立的肿瘤完全消退,包括非常大的肿瘤。
Cas No.2170491-77-5
分子式C25H20FN5O3
分子量457.46
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

AMXI-5001 is a potent, orally active, and dual parp1/2 and microtubule polymerization inhibitor. MXI-5001 exhibits selective antitumor cytotoxicity across a wide variety of human cancer cells with much lower IC50s than existing clinical PARP1/2 inhibitors. AMXI-5001 induces complete regression of established tumors, including exceedingly large tumors[1].

[1]. Lemjabbar-Alaoui H, et al. AMXI-5001, a novel dual parp1/2 and microtubule polymerization inhibitor for the treatment of human cancers. Am J Cancer Res. 2020;10(8):2649-2676.